🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Adriamycin®

Found 256 matching trials

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

PHASE2

RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...

Status

Terminated

Location

Stanford Cancer Center

Start Date

2013-05-24

Trial ID

NCT01390584

Treatments Being Tested

Doxorubicin Bleomycin Vinblastine PET INRT Dacarbazine Etoposide Cyclophosphamide Vincristine Procarbazine Prednisone

A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)

PHASE4

This is an efficacy and safety study to compare aprepitant with ondansetron...

Status

Completed

Location

Multiple Locations

Start Date

2012-12-12

Trial ID

NCT01636947

Treatments Being Tested

Aprepitant Aprepitant Placebo Ondansetron Dexamethasone Ondansetron Placebo Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride).

Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON)

N/A

The French cooperative group GINECO proposes to implement an observational ...

Status

Completed

Location

Centre de Radiothérapie et d'Oncologie

Start Date

2014-07-10

Trial ID

NCT02163720

Treatments Being Tested

Yondelis®-Caelyx®

Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)

PHASE2

The purpose of this study is to evaluate the safety and efficacy of pembrol...

Status

Completed

Location

St Joseph Heritage Healthcare-Oncology ( Site 0004)

Start Date

2021-10-07

Trial ID

NCT05008224

Treatments Being Tested

Pembrolizumab Doxorubicin Vinblastine Dacarbazine Bleomycin Etoposide Cyclophosphamide Vincristine Procarbazine Prednisone

Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients

PHASE2

This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...

Status

Completed

Location

Tower Cancer Research Foundation

Start Date

2009-10

Trial ID

NCT00931918

Treatments Being Tested

Bortezomib Rituximab Cyclophosphamide Doxorubicin Vincristine Prednisone

A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

PHASE3

The purpose of this study is to compare the effectiveness between CAELYX an...

Status

Terminated

Location

Multiple Locations

Start Date

2013-06

Trial ID

NCT01840943

Treatments Being Tested

CAELYX Topotecan HCl

Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma

PHASE2

Objectives: A. Primary objective: 1 To assess the feasibility and the eff...

Status

Completed

Location

University of Texas MD Anderson Cancer Center

Start Date

2006-09-12

Trial ID

NCT00866749

Treatments Being Tested

Daunorubicin Vincristine PEG-asparaginase Intrathecal Methotrexate Cyclophosphamide Cytarabine Mercaptopurine Methotrexate Doxorubicin Thioguanine

Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma

PHASE2

The purpose of this study is to evaluate the safety, tolerability and effic...

Status

Completed

Location

Levine Cancer Institute

Start Date

2017-05-01

Trial ID

NCT03056001

Treatments Being Tested

Pembrolizumab Doxorubicin

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

PHASE3

The safety and efficacy of pembrolizumab plus the investigator's choice of ...

Status

Active Not Recruiting

Location

University of Alabama at Birmingham-Medicine ( Site 0065)

Start Date

2021-06-18

Trial ID

NCT04895358

Treatments Being Tested

pembrolizumab paclitaxel nab-paclitaxel liposomal doxorubicin capecitabine normal saline dextrose

A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

PHASE3

This is a Phase IIIb, multinational, multicenter, randomized, open-label st...

Status

Completed

Location

Centro de Investigaciones Médicas y Desarrollo LC S.R.L

Start Date

2022-07-05

Trial ID

NCT05415215

Treatments Being Tested

Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)Pertuzumab IV Trastuzumab IV Trastuzumab Emtansine Investigator's Choice of Chemotherapy Surgery Radiotherapy

Previous Next